{"retracted":false,"update":{"timestamp":1391904000000,"doi":"10.1007/s10637-014-0069-6","type":"correction"},"doi":"10.1007/s10637-013-0062-5","journal":"Investigational New Drugs","publisher":"Springer Nature","title":"Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer"}
